CIK 0001677077
- Emerging growth company
Alzamend Neuro, Inc.
Sign in to watch- Ticker
- ALZN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Apr 30
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 811822909
- Phone
- +1 844-722-6333
- Business address
- 480 PEACHTREE ROAD NE, SECOND FLOOR, SUITE 103, ATLANTA, GA, 30326
- 8-K Event Material agreement
- 8-K Event Regulation FD disclosure
- 8-K Event Bylaws or fiscal year change · Regulation FD disclosure
- 8-K Event Shareholder vote results
- 8-K Event Regulation FD disclosure
- 8-K Event Regulation FD disclosure
- 8-K Event Exhibits
- 8-K/A Event Material agreement · Unregistered share sale · Bylaws or fiscal year change · Regulation FD disclosure
- 8-K Event Material agreement · Regulation FD disclosure
- 8-K Event Auditor change
- 8-K Event Agreement ended · Regulation FD disclosure
- 8-K Event Shareholder vote results
- 8-K Event Material agreement · New debt or obligation · Unregistered share sale
- 8-K Event Material agreement · Delisting notice · Unregistered share sale
- 8-K Event Material agreement · Shareholder rights changed · Bylaws or fiscal year change
- 8-K Event Bylaws or fiscal year change
- 8-K Event Material agreement · Delisting notice · Unregistered share sale · Bylaws or fiscal year change
- 8-K Event Executive or director change
- 8-K Event Regulation FD disclosure
- 8-K Event Bylaws or fiscal year change · Regulation FD disclosure
Page 2 of 4 · 72 filings